Literature DB >> 11773068

Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress.

Zulfiqar Ahmad1, Mohammad Salim, Mahin D Maines.   

Abstract

Human biliverdin reductase (hBVR) is a serine/threonine kinase that catalyzes reduction of the heme oxygenase (HO) activity product, biliverdin, to bilirubin. A domain of biliverdin reductase (BVR) has primary structural features that resemble leucine zipper proteins. A heptad repeat of five leucines (L(1)--L(5)), a basic domain, and a conserved alanine characterize the domain. In hBVR, a lysine replaces L(3). The secondary structure model of hBVR predicts an alpha-helix-turn-beta-sheet for this domain. hBVR translated by the rabbit reticulocyte lysate system appears on a nondenaturing gel as a single band with molecular mass of approximately 69 kDa. The protein on a denaturing gel separates into two anti-hBVR immunoreactive proteins of approximately 39.9 + 34.6 kDa. The dimeric form, but not purified hBVR, binds to a 100-mer DNA fragment corresponding to the mouse HO-1 (hsp32) promoter region encompassing two activator protein (AP-1) sites. The specificity of DNA binding is suggested by the following: (a) hBVR does not bind to the same DNA fragment with one or zero AP-1 sites; (b) a 56-bp random DNA with one AP-1 site does not form a complex with hBVR; (c) in vitro translated HO-1 does not interact with the 100-mer DNA fragment with two AP-1 sites; (d) mutation of Lys(143), Leu(150), or Leu(157) blocks both the formation of the approximately 69-kDa specimens and hBVR DNA complex formation; and (e) purified preparations of hBVR or hHO-1 do not bind to DNA with two AP-1 sites. The potential significance of the AP-1 binding is suggested by the finding that the response of HO-1, in COS cells stably transfected with antisense hBVR, with 66% reduced BVR activity, to superoxide anion (O(2)()) formed by menadione is attenuated, whereas induction by heme is not affected. We propose a role for BVR in the signaling cascade for AP-1 complex activation necessary for HO-1 oxidative stress response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11773068     DOI: 10.1074/jbc.M108239200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  The jaundice of the cell.

Authors:  David A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 2.  Biliverdin reductase isozymes in metabolism.

Authors:  Luke O'Brien; Peter A Hosick; Kezia John; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2015-02-25       Impact factor: 12.015

3.  Biliverdin reductase A in the prevention of cellular senescence against oxidative stress.

Authors:  Sung Young Kim; Hyun Tae Kang; Hae Ri Choi; Sang Chul Park
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

4.  Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt.

Authors:  Rui Zeng; Ying Yao; Min Han; Xiaoqin Zhao; Xiao-Cheng Liu; Juncheng Wei; Yun Luo; Juan Zhang; Jianfeng Zhou; Shixuan Wang; Ding Ma; Gang Xu
Journal:  J Am Soc Nephrol       Date:  2008-01-09       Impact factor: 10.121

Review 5.  HO-1 overexpression and underexpression: Clinical implications.

Authors:  George S Drummond; Jeffrey Baum; Menachem Greenberg; David Lewis; Nader G Abraham
Journal:  Arch Biochem Biophys       Date:  2019-08-16       Impact factor: 4.013

6.  Expression, purification and preliminary X-ray crystallographic analysis of cyanobacterial biliverdin reductase.

Authors:  Aya Watanabe; Kunio Hirata; Yoshinori Hagiwara; Yuko Yutani; Masakazu Sugishima; Masaki Yamamoto; Keiichi Fukuyama; Kei Wada
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-02-18

Review 7.  Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome.

Authors:  Nader G Abraham; Joshua M Junge; George S Drummond
Journal:  Trends Pharmacol Sci       Date:  2015-10-26       Impact factor: 14.819

Review 8.  Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.

Authors:  Eugenio Barone; Fabio Di Domenico; D Allan Butterfield
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

9.  Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.

Authors:  Ghassan J Maghzal; Meng-Choo Leck; Emma Collinson; Cheng Li; Roland Stocker
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

Review 10.  Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance.

Authors:  Urszula M Florczyk; Alicja Jozkowicz; Jozef Dulak
Journal:  Pharmacol Rep       Date:  2008 Jan-Feb       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.